NASDAQ · Financial Statements
Mural Oncology plc (MURA) Financial Statements
$2.04
NASDAQ: MURA
Market Cap $35.38M
Overview Financials Dividend Mural Oncology plc most recently reported annual revenue of $0, net profit of $-129.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 Revenue $0 $0 $0 $0 Operating Profit $-175.0M $-185.0M $-195.0M $-138.0M Net Profit $-175.0M $-190.0M $-207.0M $-129.0M EPS $-10.51 $-11.37 $-12.43 $-7.58 Op Margin — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 Total Assets $35.0M $34.0M $302.0M $169.0M Total Liabilities $53.0M $55.0M $38.0M $29.0M Cash $0 $0 $271.0M $115.0M Borrowings $25.0M $19.0M $15.0M $8.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 Operating Cash Flow $-157.0M $-169.0M $-194.0M $-129.0M Investing Cash Flow $-9.0M $-11.0M $-7.0M $-25.0M Financing Cash Flow $161.0M $174.0M $469.0M $0 Net Cash Flow $0 $0 $271.0M $-154.0M Free Cash Flow $-161.0M $-174.0M $-198.0M $-129.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA 0.24 FCF Yield -244.91% Quick Ratio 5.90 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock